Neugenix hero background

/By The Numbers

From Insight to Impact

Based in the heart of Illinois, Neugenix was founded to modernize the diagnostic infrastructure of addiction medicine.

About Neugenix

Science. Speed. Sobriety.

The opioid epidemic in Illinois is at an all-time high. Clinics are overwhelmed, and they need lab partners who don't just run tests - but actually understand the clinical urgency behind every specimen.

Neugenix was created to fill a critical gap. While national labs like LabCorp and Quest offer everything but specialize in nothing, and boutique labs lack the technology for comprehensive panels, Neugenix stands at the intersection of specialization and sophistication.

We're a dual-threat laboratory: toxicology testing for real-time compliance monitoring, and pharmacogenomic testing that transforms how addiction medications are prescribed. This combination doesn't exist elsewhere in Illinois - and it's exactly what the crisis demands.

Our equipment is in-house, calibrated, and validated. Our methods are built for the LC-MS/MS gold standard. Our team understands Illinois-specific billing codes, Medicaid MCO requirements, and the regulatory landscape that OTP clinics navigate every day. We didn't build a lab and then look for a market. We saw the crisis, understood the clinical need, and built the lab that addresses it.

/Mission, Vision & Values

Specialised Testing for Specialised Care.

Advanced screening and definitive testing tailored for MAT and Behavioral Health.

Our Mission

We aren't just processing samples; we are providing the definitive data that MAT (Medication-Assisted Treatment) clinics rely on to guide patients through recovery.

Our Vision

To become Illinois's most trusted clinical testing partner for addiction treatment programs, setting the national standard for integrated toxicology and pharmacogenomic services.

Our Values

  • Precision: Every test we run affects a human life. We hold ourselves to the highest standards of analytical accuracy.
  • Speed: Treatment decisions can't wait. Our 24-48 hour turnaround ensures clinicians have answers when they need them.
  • Transparency: No hidden fees. No billing surprises. No data dumps. Clear results, clear pricing, clear communication.
  • Impact: We measure success not in specimens processed, but in patients helped and clinics empowered.

Partner With Us

At Neugenix, we understand that behind every sample is a life in transition. We don't just provide data; we provide a roadmap for recovery. By combining state-of-the-art LC-MS/MS toxicology with genetic insights, we empower MAT clinics to personalise care, reduce relapse, and improve long-term patient retention.

Contact us
Partner with Neugenix

/By The Numbers

Bridging the Gap Between Science and Sobriety.

Based in the heart of Illinois, Neugenix was founded to modernize the diagnostic infrastructure of addiction medicine.

100+

Drugs & Metabolites in Our Panel

24 - 48hrs

Definitive Results Turnaround

30%

Improved Patient Retention with PGx

Download specimen guide

Download Our Specimen Guide

At Neugenix, we understand that behind every sample is a life in transition. We don't just provide data; we provide a roadmap for recovery. By combining state-of-the-art LC-MS/MS toxicology with genetic insights, we empower MAT clinics to personalise care, reduce relapse, and improve long-term patient retention.

Download

/Certifications and Compliance

Clinical Insights & Laboratory Intelligence

Stay ahead of the shifting landscape in addiction medicine. From Illinois regulatory updates to the latest breakthroughs in Pharmacogenomics, we provide the data that drives recovery.

CLIA Certified

CLIA Certified

Our laboratory holds a CLIA certificate for high-complexity testing, the highest classification issued by CMS.

HIPPA Compliant

HIPPA Compliant

Our laboratory holds a CLIA certificate for high-complexity testing, the highest classification issued by CMS.

CAP Accreditation

CAP Accreditation

Our laboratory holds a CLIA certificate for high-complexity testing, the highest classification issued by CMS.